| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.27 | 4e-06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.25 | 0.06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-09 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 9e-10 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.0005 |